Dr. Stewart discusses study of neoadjuvant axitinib in renal cell carcinoma

Video

In this video, Grant Stewart, MD, discusses the background and findings of the study, “NAXIVA – a phase II neoadjuvant study of axitinib for reducing extent of venous tumor thrombus in clear cell renal cell cancer with venous invasion: translational results.” Stewart is a professor of surgical oncology and honorary consultant urological surgeon at the University of Cambridge, England, United Kingdom.

Related Videos
Kevin Turner MA DM FRCS(Urol), answers a question during a Zoom video interview
human kidney stones medical concept | Image Credit: © freshidea - stock.adobe.com
Raveen Syan, MD, FPMRS, answers a question during a Zoom video interview
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Woman talking with doctor | Image Credit: © bongkarn - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.